| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel
1 company
Ring Christine is a Chief Legal Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $230K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.00 | $32,400.00 | -59.9% | +15.2% | -64.8% | |
| Apr 28, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 800 | $35.25 | $28,200.00 | -49.8% | -16.5% | -67.6% | |
| Apr 12, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.20 | $32,640.00 | -59.9% | -10.2% | -50.0% | |
| Mar 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 2,000 | $41.27 | $82,539.36 | -26.6% | -28.4% | -68.3% | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 2,000 | $35.88 | $71,750.35 | -48.8% | - | - |